Collections
Drug Collections

Cymbalta Litigation Documents

  

Cymbalta Withdrawal Litigation

Cymbalta (duloxetine) is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used for treating major depression, anxiety disorder, and pain associated with diabetic peripheral neuropathy or fibromyalgia. This set of documents comes from the MSJ: Hagan-Brown & Ali v. Eli Lilly and Company; Case No. 1:14-cv-01614-AJT-JFA.

The case alleges Lilly omitted important information about the drug’s withdrawal risks in the company’s labeling and marketing materials and therefore consumers were unable to make an informed choice about whether to take Cymbalta.